🎁 Black Friday: up to 50% off of annual plans
Integrated BioPharma, Inc. (INBP)
OTCMKTS · Delayed Price · Currency is USD
0.1600
0.00 (0.00%)
At close: Nov 19, 2026

Integrated BioPharma Balance Sheet

Millions USD. Fiscal year is Jul - Jun.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Equivalents
3.124.473.621.681.320.33
Short-Term Investments
-----0.01
Cash & Short-Term Investments
3.124.473.621.681.320.34
Cash Growth
-34.15%23.68%115.56%27.43%283.67%23.83%
Receivables
3.723.335.434.674.514.89
Inventory
8.559.149.3611.2410.2611.06
Other Current Assets
0.60.430.360.290.280.34
Total Current Assets
15.9817.3818.7617.8816.3716.63
Property, Plant & Equipment
4.584.832.753.684.283.78
Long-Term Deferred Tax Assets
3.323.083.344.64.734.8
Other Long-Term Assets
0.160.050.050.060.060.05
Total Assets
24.0325.3424.926.2125.4325.25

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Accounts Payable
2.823.22.272.512.273.21
Accrued Expenses
1.411.391.32.661.631.41
Short-Term Debt
-----0.1
Current Portion of Long-Term Debt
-----0.03
Current Portion of Leases
1.221.210.680.950.930.51
Total Current Liabilities
5.455.84.256.124.835.26
Long-Term Debt
-----0.05
Long-Term Leases
1.561.870.340.851.741.36
Total Liabilities
7.017.674.586.976.576.68

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Common Stock
0.060.060.060.060.060.06
Additional Paid-In Capital
5251.9751.7751.551.2450.92
Retained Earnings
-34.95-34.26-31.42-32.23-32.34-32.31
Treasury Stock
-0.1-0.1-0.1-0.1-0.1-0.1
Shareholders' Equity
17.0217.6720.3219.2418.8618.58
Total Liabilities & Equity
24.0325.3424.926.2125.4325.25

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Total Debt
2.783.081.021.82.672.06
Net Cash (Debt)
0.331.392.6-0.12-1.36-1.71
Net Cash Growth
-91.59%-46.42%----
Net Cash Per Share
0.010.040.08-0.00-0.05-0.05
Filing Date Shares Outstanding
31.0631.0631.0630.129.9529.95
Total Common Shares Outstanding
31.0631.0631.0630.129.9529.95
Working Capital
10.5211.5814.5211.7511.5411.36
Book Value Per Share
0.550.570.650.640.630.62
Tangible Book Value
17.0217.6720.3219.2418.8618.58
Tangible Book Value Per Share
0.550.570.650.640.630.62
Land
-1.251.251.251.251.25
Machinery
-7.387.257.116.86.73
Leasehold Improvements
-1.551.411.341.371.37